| Literature DB >> 28107401 |
Lívia Mizuki de Campos1, Bruna Mariah Martins1, Norberto Luiz Cabral1,2, Selma Cristina Franco1, Octávio Marques Pontes-Neto3, Suleimy Cristina Mazin3, Felipe Ibiapina Dos Reis1.
Abstract
The decrease in stroke mortality will increase the burden of survivors with functional dependence (FD). The aim of this study was to evaluate how many patients become functionally dependent over 3 years after an incident event in Joinville, Brazil. The proportion of FD (defined as a modified Rankin score 3 to 5) among stroke survivors from the Joinville Stroke Registry was assessed using a validated telephone interview. Incidence of FD after stroke in Joinville in one year was 23.24 per 100,000 population. The overall proportion of FD among stroke survivors at discharge was 32.7%. Of 303 patients with first-ever ischaemic stroke (IS), one-third were FD at discharge, and 12%, 9% and 8%, respectively at 1, 2 and 3 years. Among 37 patients with haemorrhagic stroke (HS), 38% were dependent at discharge, 16% after 1 and 2 years and 14% after 3. Among 27 patients with subarachnoid haemorrhage (SAH), 19% were dependent at discharge and 4% from 1 to 3 years. Among IS subtypes, cardioembolic ones had the worst risk of FD. (RR 19.8; 95% CI: 2.2 to 175.9). Our results showed that one-third of stroke survivors have FD during the first year after stroke in Brazil. Therefore, a city with half a million people might expect 120 new stroke patients with FD each year.Entities:
Mesh:
Year: 2017 PMID: 28107401 PMCID: PMC5249115 DOI: 10.1371/journal.pone.0170204
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of patients, risk factors, clinical severity and diagnosis.
| Total (N = 367) | IS (n = 303) | HS (n = 37) | SAH (n = 27) | ||
|---|---|---|---|---|---|
| Baseline characteristics | |||||
| Age, mean (SD) | 63.4(16.2) | 64.9(15.5) | 58.5(19.8) | 52.8(14.0) | |
| Male | 207(56.4) | 174 (57.4) | 21 (56.7) | 12 (44.4) | |
| Caucasian | 333 (90.7) | 274 (90.4) | 35 (94.6) | 24 (88.9) | |
| Education (years) | |||||
| < 8 | 245 (67.7) | 211 (70.3) | 23 (62.2) | 11 (44.0) | |
| ≥ 8 | 117 (32.3) | 89 (29.7) | 12 (32.4) | 14 (56.0) | |
| Social Class | |||||
| A | 9(2.4) | 8 (2.7) | 0 (0.0) | 1 (3.7) | |
| B1 | 8 (2.2) | 7 (2.3) | 1 (2.7) | 0 (0.0) | |
| B2 | 85 (23.2) | 70 (23.1) | 10 (27.0) | 5 (18.5) | |
| C1 | 97 (26.4) | 82 (27.1) | 6 (16.2) | 9 (33.4) | |
| C2 | 93 (25.3) | 78 (25.7) | 9 (24.3) | 6 (22.2) | |
| D | 73 (19.9) | 57 (18.8) | 11(29.8) | 5 (18.5) | |
| E | 2 (0.6) | 1 (0.3) | 0 (0.0) | 1 (3.7) | |
| Premorbid risk factor | |||||
| Hypertension | 250 (69.7) | 207 (69.9) | 28 (77.8) | 15 (55.5) | |
| Diabetes | 80 (21.9) | 72 (23.8) | 5 (13.5) | 3 (11.1) | |
| Dyslipidemia | 212 (61.1) | 173 (60.1) | 21 (61.8) | 18 (72.0) | |
| Cardiopathy | 128(34.9) | 113 (37.3) | 10 (27.0) | 5 (18.5) | |
| Physical activity | 110 (30.0) | 95(31.3) | 6 (16.2) | 9 (33.3) | |
| Previous anticoagulant use | 16 (4.4) | 13 (4.3) | 3 (8.1) | 0 | |
| Previous anti thrombotic use | 99 (27.1) | 91 (30.0) | 5 (13.5) | 3 (11.1) | |
| Smoking | |||||
| Ex | 109 (29.7) | 94 (31.0) | 10 (2.7) | 5 (18.6) | |
| No | 176 (48.0) | 147 (48.5) | 19 (51.3) | 10 (37.0) | |
| Current | 82 (22.3) | 62 (20.5) | 8 (21.6) | 12 (44.4) | |
| NIHSS,median (IQR) | 6 (15.5) | 5 (14) | 18 (19) | 16 (24.5) | |
| NIHSS | |||||
| Minor stroke | 138 (37.6) | 128 (42.2) | 4 (10.8) | 6 (22.2) | |
| Moderate stroke | 91 (24.8) | 78 (25.8) | 10 (27.0) | 3 (11.1) | |
| Moderate/Severe stroke | 36 (9.8) | 27 (8.9) | 5 (13.5) | 4 (14.8) | |
| Severe stroke | 80 (21.8) | 52 (17.2) | 17 (46.0) | 11 (40.8) | |
| TOAST | |||||
| SAO | 86(28.4) | ||||
| CE | 79(26.1) | ||||
| Undetermined | 73(24.1) | ||||
| LAA | 58(19.1) | ||||
| Other determined | 7(2.3) | ||||
| Bamford | |||||
| PACS | 116(38.3) | ||||
| LACS | 89(29.4) | ||||
| TACS | 67(22.1) | ||||
| POCS | 31(10.2) |
Data are number of patients (%) unless otherwise indicated; IS: ischaemic stroke; HS:haemorrhagic stroke; SAH: subarachnoid haemorrhage; SAO: small-artery occlusion; CE: cardioembolic; LAA: large-artery oclusion; PACS:partial anterior circulation syndrome; LACS: lacunar syndrome; TACS: total anterior circulation syndrome; POCS: posterior circulation syndrome; unavailable data:
* 5 (1.4%)
**3(0.8%)
*** 2(0.5%)
**** 8 (2.2%)
***** 1 (0.3%)
****** 20 (5.3%)
******* 2 (0.5%)
β Social class according to Brazilian Criteria of Economic Classification based on year 2013 National Household Sample Survey.
Fig 1Modified Rankin Scale (mRS) scores of 303 first-ever ischaemic stroke patients.
Proportions of patients after hospital admission, 30 days and 1 to 3 years in Joinville, 2008 to 2010; Rankin score 0 to 2: functional Independence, 3 to 5:functional dependence and 6:death.
Fig 3Modified Rankin Scale (mRS) scores of 27 first-ever sub-arachnoid haemorrages stroke patients.
Proportions of patients after hospital admission, 30 days and 1 to 3 years in Joinville, 2008 to 2010; Rankin score 0 to 2: functional Independence, 3 to 5:functional dependence and 6:death.
Fig 4Evolution of functional status of 407 patients with all stroke types measured by Rankin scale over 3-years.
Fig 5Functional status of 303 patients after incident stroke measured by Rankin scale at 30 days and 3 years.
Risk factors for functional dependence at 12, 24 and 36 months after first-ever IS stroke, adjusted relative risks, 95%confidence intervals and p-values (n = 303).
| 12 months | 24 months | 36 months | |||||
|---|---|---|---|---|---|---|---|
| Adj RR (95% CI) | p-value | Adj RR (95% CI) | p-value | Adj RR (95% CI) | p-value | ||
| Age (years) | ≥ 65 | 1.88 (0.83–4.23) | 0.128 | 3.01 (0.95–9.53) | 0.061 | 3.08 (0.82–11.57) | 0.095 |
| Sex | female vs male | 1.28 (0.53–3.09) | 0.579 | 1.23 (0.39–3.93) | 0.722 | 0.66 (0.17–2.52) | 0.547 |
| Years of education | ≥ 8 | 0.81 (0.13–5.07) | 0.821 | 0.22 (0.01–3.44) | 0.280 | 0.59 (0.03–10.43) | 0.719 |
| Social Class | A / B | 2.66 (0.68–10.42) | 0.161 | 3.25 (0.56–18.72) | 0.188 | 1.84 (0.28–12.22) | 0.529 |
| C | 1.94 (0.64–5.90) | 0.244 | 1.94 (0.46–8.14) | 0.368 | 2.22 (0.39–12.73) | 0.373 | |
| Race | caucasian | 1.44 (0.46–4.50) | 0.532 | 2.11 (0.40–11.07) | 0.377 | 3.11 (0.34–28.25) | 0.313 |
| Hypertension | yes | 1.35 (0.55–3.32) | 0.509 | 1.42 (0.45–4.50) | 0.552 | 0.80 (0.22–2.83) | 0.723 |
| Diabetes | yes | 1.67 (0.66–4.24) | 0.284 | 1.39 (0.43–4.53) | 0.585 | 1.48 (0.34–6.40) | 0.601 |
| Smoking | yes | 1.62 (0.60–4.33) | 0.338 | 3.23 (0.99–10.58) | 0.053 | 2.81 (0.80–9.95) | 0.108 |
| Dyslipidemia Control | yes | 0.72 (0.28–1.85) | 0.495 | 0.71 (0.22–2.27) | 0.565 | 0.89 (0.23–3.38) | 0.858 |
| TOAST | LAA | 11.63 (1.31–103.21) | 0.028 | 3.47 (0.55–21.73) | 0.184 | 2.04 (0.36–11.68) | 0.425 |
| CE | 19.80 (2.24–174.85) | 0.007 | 11.82 (1.77–78.96) | 0.011 | 5.29 (0.82–33.92) | 0.079 | |
| UND | 8.34 (0.95–73.24) | 0.056 | 2.55 (0.40–16.10) | 0.320 | 0.30 (0.03–3.29) | 0.322 | |
| Other | 16.68 (1.31–212.30) | 0.030 | 4.38 (0.22–88.52) | 0.336 | 2.49 (0.19–32.11) | 0.486 | |
| Bamford | PACS | 1.10 (0.35–3.51) | 0.868 | 0.50 (0.13–1.96) | 0.316 | 1.75 (0.40–7.64) | 0.459 |
| POCS | 2.07 (0.50–8.55) | 0.314 | 0.36 (0.04–3.38) | 0.372 | 0.63 (0.07–6.19) | 0.694 | |
| TACS | 3.68 (0.83–16.35) | 0.087 | 0.97 (0.13–7.19) | 0.973 | 4.38 (0.41–47.36) | 0.224 | |
| Physical activity | yes | 0.32 (0.10–1.01) | 0.052 | 0.32 (0.07–1.37) | 0.124 | 0.33 (0.07–1.63) | 0.174 |
| Cardiopathy | yes | 1.49 (0.61–3.66) | 0.380 | 0.59 (0.15–2.37) | 0.459 | 1.27 (0.26–6.16) | 0.770 |
| NIHSS | Severe | 1.13 (0.34–3.82) | 0.840 | 3.30 (0.62–17.64) | 0.163 | 0.69 (0.08–5.93) | 0.732 |
Adj RR: Adjusted Relative Risk; IS: Ischaemic Stroke
β Social class according to Brazilian Criteria of Economic Classification based on year 2013 National Household Sample Survey
LAA: large-artery oclusion; SAO: small-artery occlusion; CE: Cardioembolic; UND: Undetermined; PACS: Partial Anterior Circulation Syndrome; LACS: Lacunar Syndrome; TACS: Total Anterior Circulation Syndrome; POCS: Posterior Circulation Syndrome.